Cel-Sci Corporation (CVM) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
8229 BOONE BLVD . VIENNA, VA 22182 |
| State of Incorp. | CO |
| Fiscal Year End | September 30 |
| Industry (SIC) | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2025 MRQ | 9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 250 | 250 | 22,672 | 42,212 | 15,509 | ||||
| Cash and cash equivalent | 250 | 250 | 22,672 | 36,060 | 15,509 | ||||
| Short-term investments | 6,151 | ||||||||
| Receivables | 55 | 55 | |||||||
| Inventory, net of allowances, customer advances and progress billings | 1,020 | 2,248 | 2,002 | 2,007 | 820 | ||||
| Inventory | 1,020 | 2,248 | 2,002 | 2,007 | 820 | ||||
| Prepaid expense | 332 | 294 | 520 | 762 | 998 | 1,313 | |||
| Deposits current assets | 7 | 4 | 4 | ||||||
| Other undisclosed current assets | 11,257 | 4,488 | 3,896 | ||||||
| Total current assets: | 11,596 | 6,056 | 6,918 | 25,436 | 45,272 | 17,697 | |||
| Noncurrent Assets | |||||||||
| Inventory, Noncurrent | 1,475 | 75 | 164 | ||||||
| Finance lease, right-of-use asset, after accumulated amortization | 5,548 | 7,350 | 9,132 | 10,938 | 12,692 | 13,812 | |||
| Operating lease, right-of-use asset | 1,275 | 1,496 | 1,698 | 1,884 | 2,056 | 1,199 | |||
| Property, plant, and equipment, after accumulated depreciation, depletion, and amortization | 6,079 | 8,130 | 10,188 | 11,889 | 13,664 | 5,844 | |||
| Intangible asset, including goodwill, after accumulated amortization | 240 | 165 | 198 | 212 | 276 | 313 | |||
| Intangible asset, excluding goodwill, after accumulated amortization | 240 | 165 | 198 | 212 | 276 | 313 | |||
| Deposits noncurrent assets | 2,319 | 2,319 | 2,319 | ||||||
| Other undisclosed noncurrent assets | 1,099 | 1,911 | (19,468) | ||||||
| Total noncurrent assets: | 16,560 | 20,936 | 23,610 | 25,088 | 30,598 | 1,700 | |||
| Other undisclosed assets | 21,139 | ||||||||
| TOTAL ASSETS: | 28,156 | 26,992 | 30,528 | 50,524 | 75,870 | 40,536 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 1,773 | 2,015 | 3,059 | 2,461 | 2,535 | 2,534 | |||
| Accounts payable | 1,061 | 1,448 | 2,010 | 1,618 | 1,676 | 2,023 | |||
| Accrued liabilities | 712 | 566 | 1,050 | 842 | 859 | 511 | |||
| Debt | 2,274 | 2,011 | 1,772 | ||||||
| Derivative instruments and hedges, liabilities | 437 | 214 | |||||||
| Due to related parties | ✕ | ✕ | ✕ | ✕ | 471 | 266 | 448 | ||
| Other undisclosed current liabilities | 1,083 | 590 | 755 | 1,731 | 699 | 1,070 | |||
| Total current liabilities: | 5,131 | 4,616 | 5,586 | 4,664 | 3,937 | 4,266 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation, including: | 5,684 | 7,958 | 9,950 | 13,572 | 15,274 | 12,867 | |||
| Finance lease, liability | 5,684 | 7,958 | 9,950 | 11,721 | 13,252 | 11,753 | |||
| Other undisclosed long-term debt and lease obligation | (0) | ||||||||
| Liabilities, other than long-term debt | 1,384 | 1,551 | 1,778 | 125 | 125 | 3,677 | |||
| Other liabilities | 125 | 125 | 125 | 125 | 125 | 125 | |||
| Operating lease, liability | 1,259 | 1,426 | 1,653 | 1,850 | 2,021 | 1,114 | |||
| Derivative instruments and hedges, liabilities | 3,552 | ||||||||
| Other undisclosed noncurrent liabilities | 0 | ||||||||
| Total noncurrent liabilities: | 7,068 | 9,509 | 11,728 | 13,697 | 15,399 | 16,544 | |||
| Total liabilities: | 12,199 | 14,125 | 17,313 | 18,360 | 19,336 | 20,810 | |||
| Equity | |||||||||
| Equity, attributable to parent | 15,957 | 12,867 | 13,215 | 32,163 | 56,534 | 19,727 | |||
| Common stock | 80 | 638 | 474 | 434 | 432 | 387 | |||
| Additional paid in capital | 555,300 | 526,241 | 499,832 | 486,626 | 474,299 | 401,175 | |||
| Accumulated deficit | (539,423) | (514,012) | (487,091) | (454,897) | (418,196) | (381,835) | |||
| Total equity: | 15,957 | 12,867 | 13,215 | 32,163 | 56,534 | 19,727 | |||
| TOTAL LIABILITIES AND EQUITY: | 28,156 | 26,992 | 30,528 | 50,524 | 75,870 | 40,536 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2025 TTM | 9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 48 | 559 | ||||||
| Other income | 48 | 559 | ||||||
| Gross profit: | 48 | 559 | ||||||
| Operating expenses | (24,810) | (26,352) | (31,476) | (36,063) | (36,194) | (29,544) | ||
| Other undisclosed operating loss | (48) | |||||||
| Operating loss: | (24,810) | (26,352) | (31,476) | (36,063) | (36,194) | (28,985) | ||
| Nonoperating income (expense) | 48 | 178 | (43) | 77 | 1,677 | 926 | ||
| Investment income, nonoperating | (30) | 1,685 | 888 | |||||
| Other nonoperating income (expense) | 48 | 178 | (43) | 107 | (8) | 39 | ||
| Interest and debt expense | (675) | (1,200) | ||||||
| Loss from continuing operations before equity method investments, income taxes: | (24,762) | (26,175) | (32,194) | (35,986) | (34,517) | (29,259) | ||
| Other undisclosed loss from continuing operations before income taxes | (997) | |||||||
| Loss from continuing operations: | (24,762) | (26,175) | (32,194) | (35,986) | (34,517) | (30,255) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (35,986) | (34,517) | (30,255) | |
| Other undisclosed net income (loss) | 50,173 | (746) | 72,687 | |||||
| Net income (loss): | 25,411 | (26,920) | (32,194) | 36,701 | (34,517) | (30,255) | ||
| Other undisclosed net loss attributable to parent | (50,822) | (659) | (73,401) | (1,844) | ||||
| Net loss attributable to parent: | (25,411) | (27,580) | (32,194) | (36,701) | (36,361) | (30,255) | ||
| Other undisclosed net loss available to common stockholders, basic | (172) | (929) | (351) | (22) | ||||
| Net loss available to common stockholders, basic: | (25,411) | (27,580) | (32,366) | (37,630) | (36,712) | (30,277) | ||
| Other undisclosed net loss available to common stockholders, diluted | (1,086) | |||||||
| Net loss available to common stockholders, diluted: | (25,411) | (27,580) | (32,366) | (37,630) | (37,798) | (30,277) | ||
Comprehensive Income ($ in thousands)
| 12/31/2025 TTM | 9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 25,411 | (26,920) | (32,194) | 36,701 | (34,517) | (30,255) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 25,411 | (26,920) | (32,194) | 36,701 | (34,517) | (30,255) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.